Featured Research

from universities, journals, and other organizations

Bone Marrow Stem Cells May One Day Help Treat Damaged Livers

Date:
May 15, 2003
Source:
Washington University School Of Medicine
Summary:
Research at Washington University School of Medicine in St. Louis suggests that stem cells from bone marrow or umbilical cord blood may be useful for treating people with liver damage due to cirrhosis, viral infection, trauma, chemotherapy or radiation therapy.

St. Louis, May 14, 2003 -- Research at Washington University School of Medicine in St. Louis suggests that stem cells from bone marrow or umbilical cord blood may be useful for treating people with liver damage due to cirrhosis, viral infection, trauma, chemotherapy or radiation therapy.

Related Articles


The study, done in immune deficient mice, showed that human stem cells that normally produce blood cells also can form liver-like cells in a damaged liver. The findings are published in the May 15 issue of the journal Blood.

"There is a huge demand for liver transplants but there are never enough organs, and the procedure is not always successful," says study leader Jan A. Nolta, Ph.D., associate professor of medicine. "We're hoping that in the future we can use bone marrow or umbilical cord blood stem cells from matched donors to help treat liver disease and reduce the need for liver transplants."

Nolta and her colleagues isolated highly purified human stem cells from bone marrow and umbilical cord blood and transplanted them into immune-deficient mice. The purified stem cells normally give rise to cells that mature into red blood cells and white blood cells.

A month later, after the human stem cells had established themselves in the animal's bone marrow, the investigators induced liver damage. Some mice also were given human hepatocyte growth factor to increase the number of stem cells that developed, or differentiated, into liver cells (also known as hepatocytes).

A month after inducing the liver damage, the investigators compared the damaged organs to healthy ones from control mice that also had been transplanted with human stem cells. They tested the livers for the presence of human albumin, a protein produced only by liver cells. Any human albumin found in these mice would have to have come from transplanted human stem cells that had developed into liver-like cells.

Nolta and her colleagues found the greatest number of human-albumin-producing cells in the damaged livers of mice that had been treated with human hepatocyte growth factor. In some cases, albumin began showing up as early as five days after treatment. The number of stem cells that had differentiated into liver-like cells was low, however, making up less than 1 percent of all liver cells. Human albumin was not detected in mice with healthy livers.

The investigators believe that the stem cells moved from the bone marrow into the circulating blood, then left the blood to reside in the damaged liver, where they became liver-like cells that produced human albumin.

"These results show that human stem cells from bone marrow and umbilical cord blood are a potential source of liver cells," says Nolta, who also is a member of the Hematopoietic Development and Malignancy Research Program at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

The study also represents the first successful animal model for studying how stem cells from human bone marrow and umbilical cord blood might be used to treat liver disease.

Nolta and her colleagues now are working to increase the number of human stem cells that differentiate into liver cells in this model by studying the signals that draw the cells into the liver and control their transformation, a feature known as stem-cell plasticity. In addition, they are investigating the use of blood-forming stem cells for the repair of heart and skeletal muscle.

###

Wang X, Ge S, McNamara G, Hao Q-L, Crooks GM, Nolta JA. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood, 101 (10), 4201-4208, May 15, 2003.

Funding from the National Heart, Lung, and Blood Institute and from the National Institute of Diabetes and Digestive and Kidney Diseases supported this research.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Bone Marrow Stem Cells May One Day Help Treat Damaged Livers." ScienceDaily. ScienceDaily, 15 May 2003. <www.sciencedaily.com/releases/2003/05/030515074503.htm>.
Washington University School Of Medicine. (2003, May 15). Bone Marrow Stem Cells May One Day Help Treat Damaged Livers. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2003/05/030515074503.htm
Washington University School Of Medicine. "Bone Marrow Stem Cells May One Day Help Treat Damaged Livers." ScienceDaily. www.sciencedaily.com/releases/2003/05/030515074503.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins